PMV Pharmaceuticals is collaborating with MD Anderson Cancer Center (MDACC) and Memorial Sloan Kettering Cancer Center (MSK) to support an investigator-initiated Phase 1b study evaluating rezatapopt ...

U.S. equities finished higher during the third quarter, with 10 of 11 GICS sectors posting positive returns. Click here to ...

During the monitoring period, after the seasonal influenza period had ended, 59 wastewater treatment plants showed increases ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently published a list of 10 Most Promising Low-Cost Stocks According to Hedge Funds. In this article, we are going to ...

The Marian Catholic High School Sports Hall of Fame will induct 10 former student-athletes into its fraternity during a ...

Merck's P/S multiple is roughly 4, and its P/FCF is 21. That makes its valuation a bit pricier than Pfizer's per dollar of revenue, but significantly cheaper per dollar of free cash flow. In other ...

The Fund returned 7.38% versus 5.89% for the S&P 500 Index for the quarter, and 12.86% since inception versus 10.67% for the ...

Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility ...

The global polylysine market is estimated to reach a valuation of USD 728.6 million in 2024. Over the forecast period, global polylysine demand will likely grow at 10.1% CAGR, taking the overall ...

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate ...

The Sabin Vaccine Institute falls into this latter category. The institute acquired the rights to a Marburg vaccine candidate ...